Although the current study did not demonstrate a diagnostic role of saliva NT-proBNP, the association between saliva and serum levels of NT-proBNP in ADHF patients may suggest that saliva NT-proBNP could potentially be used for monitoring of treatment effects in patients with acute HF (in-hospital or early post-discharge), using serial measurements. This evidence concerns the gene NPPB and hydrops fetalis.